ProstaLund (OM:PLUN BTA) - Stock Price, News & Analysis

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

PLUN BTA Stock Overview

A medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally.

About the company

PLUN BTA fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Rewards

Risk Analysis

Has less than 1 year of cash runway

Shares are highly illiquid

Does not have meaningful revenue (SEK18M)

Does not have a meaningful market cap (SEK219M)

+ 1 more risk

ProstaLund AB (publ) Competitors

Ortoma

OM:ORT B

SEK 333.8m

Glycorex Transplantation

NGM:GTAB B

SEK 166.2m

Nanexa

OM:NANEXA

SEK 214.4m

Dignitana

OM:DIGN

SEK 67.3m

Price History & Performance

Summary of all time highs, changes and price drops for ProstaLund
Historical stock prices
Current Share Price	SEK 2.60
52 Week High	SEK 3.09
52 Week Low	SEK 1.71
Beta	1.02
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	37.57%

Recent updates

Shareholder Returns

	PLUN BTA	SE Medical Equipment	SE Market
7D	19.8%	0.6%	1.6%
1Y	n/a	22.1%	25.5%

Return vs Industry: Insufficient data to determine how PLUN BTA performed against the Swedish Medical Equipment industry.

Return vs Market: Insufficient data to determine how PLUN BTA performed against the Swedish Market.

Price Volatility

Is PLUN BTA's price volatile compared to industry and market?
PLUN BTA volatility
PLUN BTA Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	7.6%
Market Average Movement	5.6%
10% most volatile stocks in SE Market	11.6%
10% least volatile stocks in SE Market	3.2%

Stable Share Price: PLUN BTA's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine PLUN BTA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1991	9	Johan Wennerholm	prostalund.se

ProstaLund AB (publ), a medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. It offers CoreTherm, a heat treatment for benign prostate enlargement; CoreFlow soft stent; Oruflow, a urine flow meter; Dosi-Fuser, a disposable continuous infusion system; and Dosi-Flow, a gravitation unit with a flow regulator for dosing of medicines. The company also provides Schelin Catheter, an injection tool that allows the urologists to administer drugs into the prostate in a sterile way through the urethra.

ProstaLund AB (publ) Fundamentals Summary

How do ProstaLund's earnings and revenue compare to its market cap?
PLUN BTA fundamental statistics
Market cap	SEK 219.04m
Earnings (TTM)	-SEK 12.17m
Revenue (TTM)	SEK 18.43m

11.9x

P/S Ratio

-18.0x

P/E Ratio

Is PLUN BTA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PLUN BTA income statement (TTM)
Revenue	SEK 18.43m
Cost of Revenue	SEK 5.47m
Gross Profit	SEK 12.96m
Other Expenses	SEK 25.13m
Earnings	-SEK 12.17m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

Jul 14, 2023

Earnings per share (EPS)	-0.16
Gross Margin	70.32%
Net Profit Margin	-66.06%
Debt/Equity Ratio	4.2%

How did PLUN BTA perform over the long term?

See historical performance and comparison

ProstaLund OM:PLUN BTA Stock Report